169 related articles for article (PubMed ID: 11773861)
1. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.
Marchal-Victorion S; Vionnet N; Escrieut C; Dematos F; Dina C; Dufresne M; Vaysse N; Pradayrol L; Froguel P; Fourmy D
Pharmacogenetics; 2002 Jan; 12(1):23-30. PubMed ID: 11773861
[TBL] [Abstract][Full Text] [Related]
2. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
3. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
Escrieut C; Gigoux V; Archer E; Verrier S; Maigret B; Behrendt R; Moroder L; Bignon E; Silvente-Poirot S; Pradayrol L; Fourmy D
J Biol Chem; 2002 Mar; 277(9):7546-55. PubMed ID: 11724786
[TBL] [Abstract][Full Text] [Related]
4. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
5. Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.
Reubi JC; Waser B; Gugger M; Friess H; Kleeff J; Kayed H; Büchler MW; Laissue JA
Gastroenterology; 2003 Jul; 125(1):98-106. PubMed ID: 12851875
[TBL] [Abstract][Full Text] [Related]
6. Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.
Fourmy D; Escrieut C; Archer E; Galès C; Gigoux V; Maigret B; Moroder L; Silvente-Poirot S; Martinez J; Fehrentz JA; Pradayrol L
Pharmacol Toxicol; 2002 Dec; 91(6):313-20. PubMed ID: 12688374
[TBL] [Abstract][Full Text] [Related]
7. Biology of gut cholecystokinin and gastrin receptors.
Shulkes A; Baldwin GS
Clin Exp Pharmacol Physiol; 1997; 24(3-4):209-16. PubMed ID: 9131287
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade.
Mazzocchi G; Malendowicz LK; Aragona F; Spinazzi R; Nussdorfer GG
J Clin Endocrinol Metab; 2004 Mar; 89(3):1277-84. PubMed ID: 15001623
[TBL] [Abstract][Full Text] [Related]
9. Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.
Galés C; Poirot M; Taillefer J; Maigret B; Martinez J; Moroder L; Escrieut C; Pradayrol L; Fourmy D; Silvente-Poirot S
Mol Pharmacol; 2003 May; 63(5):973-82. PubMed ID: 12695525
[TBL] [Abstract][Full Text] [Related]
10. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
[TBL] [Abstract][Full Text] [Related]
11. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
[TBL] [Abstract][Full Text] [Related]
12. Further evidence that the CCK2 receptor is coupled to two transduction pathways using site-directed mutagenesis.
Pommier B; Marie-Claire C; Da Nascimento S; Wang HL; Roques BP; Noble F
J Neurochem; 2003 Apr; 85(2):454-61. PubMed ID: 12675921
[TBL] [Abstract][Full Text] [Related]
13. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.
Morton MF; Pyati J; Dai H; Li L; Moreno V; Shankley NP
Br J Pharmacol; 2005 Jun; 145(3):374-84. PubMed ID: 15765098
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor.
Archer-Lahlou E; Escrieut C; Clerc P; Martinez J; Moroder L; Logsdon C; Kopin A; Seva C; Dufresne M; Pradayrol L; Maigret B; Fourmy D
J Biol Chem; 2005 Mar; 280(11):10664-74. PubMed ID: 15632187
[TBL] [Abstract][Full Text] [Related]
17. Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.
Berna MJ; Jensen RT
Curr Top Med Chem; 2007; 7(12):1211-31. PubMed ID: 17584143
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor.
Silvente-Poirot S; Escrieut C; Galès C; Fehrentz JA; Escherich A; Wank SA; Martinez J; Moroder L; Maigret B; Bouisson M; Vaysse N; Fourmy D
J Biol Chem; 1999 Aug; 274(33):23191-7. PubMed ID: 10438490
[TBL] [Abstract][Full Text] [Related]
19. CCK-B/gastrin receptors in human colorectal cancer.
Schmitz F; Otte JM; Stechele HU; Reimann B; Banasiewicz T; Fölsch UR; Schmidt WE; Herzig KH
Eur J Clin Invest; 2001 Sep; 31(9):812-20. PubMed ID: 11589724
[TBL] [Abstract][Full Text] [Related]
20. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
Wang HL
J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
